---
figid: PMC2948329__1757-5931-0001-0000000093-g002
figtitle: TSC1/2 integrates multiple signals to control cell growth and proliferation
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC2948329
filename: 1757-5931-0001-0000000093-g002.jpg
figlink: /pmc/articles/PMC2948329/figure/fig-002/
number: F2
caption: Growth factors stimulate the MAPK and insulin signaling pathways, leading
  to TSC2 phosphorylation and inactivation. TSC1/2 negatively regulates mTORC1 through
  its actions on Rheb, while it positively regulates mTORC2. The insulin signaling
  pathway can activate mTORC1 without going through TSC1/2 by Akt phosphorylation
  of PRAS40, an inhibitor of mTORC1, thereby relieving the inhibition. Similarly,
  the MAPK signaling pathway can activate mTORC1 without going through TSC1/2 via
  RSK phosphorylation of raptor, a component of the mTORC1 complex, leading to mTORC1
  activation. Activation of mTORC1 leads to protein translation and to a negative
  feedback loop on the activation of the insulin and MAPK signaling pathways. In the
  presence of amino acids, the Rag GTPase heterodimers promote the localization of
  mTORC1 to cellular compartments containing Rheb, thereby promoting mTORC1 activation.
  In conditions of low cellular energy or hypoxia, AMPK phosphorylates and activates
  TSC2, while hypoxia increases the transcription of REDD1, which also activates TSC2,
  leading to inhibition of translation. TSC2 binds p27Kip1, a cyclin-dependent kinase
  inhibitor, stabilizing it and resulting in inhibition of cell cycle progression.
  Sirolimus, or rapamycin, inhibits mTORC1, while CI-1040 is an MAPK/ERK inhibitor.
  Roscovitine is an inhibitor of CDK2. 4E-BP1, factor 4E-binding protein 1; Akt, protein
  kinase B; AMPK, AMP-dependent protein kinase; CDK2, cyclin-dependent kinase 2; ERK1/2,
  extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; mTORC,
  mammalian target of rapamycin complex; PDK1, pyruvate dehydrogenase kinase, isozyme
  1; PI3K, phosphoinositide 3-kinase; PRAS40, proline-rich protein kinase B substrate
  of 40 kDa; Rag, Ras-related small GTP-binding protein; REDD1, regulated in the development
  and DNA damage response 1; Rheb, Ras homolog enriched in brain; RSK, p90 ribosomal
  S6 kinase; S6K1, S6 kinase 1; TSC, tuberous sclerosis complex.
papertitle: 'Therapeutic options for lymphangioleiomyomatosis (LAM): where we are
  and where we are going.'
reftext: Angelo M Taveira-DaSilva, et al. F1000 Med Rep. 2009;1:93.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9589152
figid_alias: PMC2948329__F2
figtype: Figure
redirect_from: /figures/PMC2948329__F2
ndex: 9e138503-dece-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2948329__1757-5931-0001-0000000093-g002.html
  '@type': Dataset
  description: Growth factors stimulate the MAPK and insulin signaling pathways, leading
    to TSC2 phosphorylation and inactivation. TSC1/2 negatively regulates mTORC1 through
    its actions on Rheb, while it positively regulates mTORC2. The insulin signaling
    pathway can activate mTORC1 without going through TSC1/2 by Akt phosphorylation
    of PRAS40, an inhibitor of mTORC1, thereby relieving the inhibition. Similarly,
    the MAPK signaling pathway can activate mTORC1 without going through TSC1/2 via
    RSK phosphorylation of raptor, a component of the mTORC1 complex, leading to mTORC1
    activation. Activation of mTORC1 leads to protein translation and to a negative
    feedback loop on the activation of the insulin and MAPK signaling pathways. In
    the presence of amino acids, the Rag GTPase heterodimers promote the localization
    of mTORC1 to cellular compartments containing Rheb, thereby promoting mTORC1 activation.
    In conditions of low cellular energy or hypoxia, AMPK phosphorylates and activates
    TSC2, while hypoxia increases the transcription of REDD1, which also activates
    TSC2, leading to inhibition of translation. TSC2 binds p27Kip1, a cyclin-dependent
    kinase inhibitor, stabilizing it and resulting in inhibition of cell cycle progression.
    Sirolimus, or rapamycin, inhibits mTORC1, while CI-1040 is an MAPK/ERK inhibitor.
    Roscovitine is an inhibitor of CDK2. 4E-BP1, factor 4E-binding protein 1; Akt,
    protein kinase B; AMPK, AMP-dependent protein kinase; CDK2, cyclin-dependent kinase
    2; ERK1/2, extracellular signal-regulated kinase; MAPK, mitogen-activated protein
    kinase; mTORC, mammalian target of rapamycin complex; PDK1, pyruvate dehydrogenase
    kinase, isozyme 1; PI3K, phosphoinositide 3-kinase; PRAS40, proline-rich protein
    kinase B substrate of 40 kDa; Rag, Ras-related small GTP-binding protein; REDD1,
    regulated in the development and DNA damage response 1; Rheb, Ras homolog enriched
    in brain; RSK, p90 ribosomal S6 kinase; S6K1, S6 kinase 1; TSC, tuberous sclerosis
    complex.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - APRT
  - MFAP1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC1
  - CCL26
  - DDIT4
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - AKT1S1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - CDK2
  - RPTOR
  - RHEB
  - RHEBP1
  - EIF4EBP1
  - Pik3r1
  - Ephb2
  - Mapk1
  - Mapk3
  - Rps6ka1
  - Tsc1
  - Ddit4
  - Pdk1
  - Pdpk1
  - Akt1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Akt1s1
  - Cdk2
  - Rheb
  - Eif4ebp1
  - Rps6kb1
  - Pik3cg
  - Ephb1
  - Tmprss5
  - Prkaa2
  - Tmed7
  - Ccne1
  - MKP-4
  - p38b
  - rl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Erk7
  - Amph
  - S6kII
  - SNF4Agamma
  - AMPKalpha
  - Akt
  - DCTN6-p27
  - dap
  - CG9588
  - PRAS40
  - Crtc
  - Thor
  - S6k
  - CycE
  - cyc
  - rag
  - RagA-B
  - rags
  - sirolimus
---
